Back
Avalo Therapeutics Stock Predictions
The dark truth about AI
Click here to learn more...
Sell
31
AVTX
Avalo Therapeutics
Last Price:
9.30
Seasonality Move:
10.12%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Avalo Therapeutics Stock Forecast
- Over the next 52 weeks, Avalo Therapeutics has on average historically fallen by 18.6% based on the past 9 years of stock performance.
- Avalo Therapeutics has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Avalo Therapeutics Stock Undervalued?
The current Avalo Therapeutics [AVTX] share price is $9.23. The Score for AVTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal. - AVTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Avalo Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Avalo Therapeutics has on average historically fallen by 18.6% based on the past 9 years of stock performance.
Avalo Therapeutics Stock Rating
Sell
31
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics overpriced?
- Avalo Therapeutics has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Avalo Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
avalotx.com
52-Week Data
52-Week High:
34.46
52-Week Low:
3.95
Prediction Charts
Market Cap:
96.58M
Price in USD:
9.23
Volume:
189.1K
Beta:
1.21
Technical Analysis
SMA50:
11.17
SMA100:
10.35
SMA200:
10.89
52-Wk Change:
-34.82%
Stock Predictions
-
Is Avalo Therapeutics stock public?
Yes, Avalo Therapeutics is a publicly traded company. -
What is the Avalo Therapeutics stock quote today?
The Avalo Therapeutics stock price is 9.23 USD today. -
How to buy Avalo Therapeutics stock online?
You can buy Avalo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-25 | 10.00 | 9.83 | 10.50 | 9.57 |
| Nov-26 | 9.85 | 9.99 | 9.99 | 9.14 |
| Nov-27 | 9.99 | 9.55 | 9.99 | 9.31 |
| Nov-29 | 9.55 | 9.55 | 10.00 | 9.38 |
| Dec-2 | 9.48 | 9.85 | 10.00 | 9.11 |
| Dec-3 | 9.58 | 9.96 | 10.10 | 9.35 |
| Dec-4 | 9.95 | 10.00 | 10.26 | 9.81 |
| Dec-5 | 9.93 | 9.98 | 10.00 | 9.71 |
| Dec-6 | 9.70 | 10.15 | 10.46 | 9.67 |
| Dec-9 | 10.32 | 10.50 | 10.50 | 9.99 |
| Dec-10 | 10.63 | 9.69 | 12.00 | 9.44 |
| Dec-11 | 9.65 | 9.39 | 9.90 | 9.06 |
| Dec-12 | 9.23 | 9.11 | 9.63 | 8.90 |
| Dec-13 | 9.29 | 9.23 | 9.40 | 8.77 |
Avalo Therapeutics Earnings
Avalo Therapeutics Earnings Report: Per Share Avalo Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Avalo Therapeutics Forecast Revenue Growth
Avalo Therapeutics Stock Analysis: Historical quarterly revenues per share for Avalo Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.00 per share.
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.